Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lonza announced its entry into a binding contractual commitment for the purchase of a sterile drug product fill & finish facility from Novartis.
read more
DSP Clinical has announced a new co-monitoring service that provides flexible monitoring support to help clinical trials meet study timelines.
read more
Catalent held a ground breaking ceremony at its Bloomington, Indiana site to mark the start of construction on a $112 million drug product manufacturing facility.
read more
FUJIFILM Irvine Scientific announced plans to open a third manufacturing facility located in Tilburg, Netherlands.
read more
Passage Bio has entered into a collaboration agreement with Paragon Gene Therapy for the development of a dedicated manufacturing suite at their facility near Baltimore.
read more
Catalent has expanded the capacity of its global spray drying operations through an agreement with Sanofi Active Ingredient Solutions.
read more
Avid Bioservices has signed two new contract manufacturing service agreements to support the development of novel drug candidates.
read more
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
read more
Nexus Pharmaceuticals announced an agreement with the village of Pleasant Prairie, Wisconsin to build a sterile injectable manufacturing facility.
read more
Schrödinger announced receipt of a preclinical milestone payment from Sanofi in a drug discovery program advancing as part of a multi-year, multi-target collaboration
read more
Agilent Technologies has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion.
read more
Amneal Pharmaceuticals has announced a restructuring plan designed to reduce its cost base to and optimize its global manufacturing infrastructure.
read more
SI Group has announced an agreement to sell the majority of its global industrial resin businesses and its Brazilian specialty business to ASK Chemicals.
read more
GVK BIO has announced the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of Directors.
read more
IDT Biologika announced the NIAID of the NIH has awarded the company a new Task Order within the 10-year contract to provide manufacturing of five E. coli Master Cell Banks.
read more